News & Updates

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Regular statin users appear to be at lower risk of developing diabetes mellitus following an episode of acute pancreatitis, as shown in a study.

Regular statin use offers protection against diabetes in acute pancreatitis patients

27 Jun 2022

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Among type 2 diabetes (T2D) patients on first-generation basal insulins (1BIs), a switch to either glargine or degludec in the real-world setting leads to marked improvements in glucose control without increasing the risk of hypoglycaemic events and weight gain, according to a study. Furthermore, the benefits seem to be comparable between the two second-generation basal insulins (2BIs).

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

27 Jun 2022

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data

27 Jun 2022 by

Older adults have weaker antibody responses to two doses of COVID-19 vaccines [ie, mRNA-based BNT162b2 vaccine and inactivated CZ02 vaccine] vs younger individuals, but a booster dose mounts SARS-CoV-2 neutralization activities to a high level, according to data presented at AIM 2022.

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data

27 Jun 2022

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

In type 2 diabetes (T2D) patients with obesity, calorie restriction helps correct several cardiovascular (CV) risk factors and glomerular hyperfiltration, with the latter translating into a relative long-term stabilization of kidney function, according to a study.

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

26 Jun 2022

Revacept beneficial to patients with symptomatic ICA stenosis

26 Jun 2022

Patients with symptomatic internal carotid artery (ICA) stenosis may fare well with revacept, a competitive antagonist of glycoprotein VI, as the drug helps reduce the incidence of stroke or death, transient ischaemic attack, and bleeding complications, among others, according to a study.

Revacept beneficial to patients with symptomatic ICA stenosis

26 Jun 2022

Specific carbohydrate diet may improve symptoms for some IBD patients

26 Jun 2022

A specific carbohydrate diet (SCD) and a modified SCD (MSCD) demonstrate inconsistent effectiveness for the improvement of symptoms in inflammatory bowel disease (IBD), with some patients benefitting and others not, reports a study.

Specific carbohydrate diet may improve symptoms for some IBD patients

26 Jun 2022

$Add-on baclofen eases reflux in certain PPI-refractory GERD patients$

Add-on baclofen eases reflux in certain PPI-refractory GERD patients

26 Jun 2022

In patients with proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD), add-on treatment with baclofen improves several reflux parameters, but only among those who are positive for symptom association probability, a study has found.

Add-on baclofen eases reflux in certain PPI-refractory GERD patients

26 Jun 2022

P-gp/CYP3A4 inhibitor use ups bleeding, mortality risks in NOAC-treated AF patients

26 Jun 2022

Bleeding and mortality risks are elevated in atrial fibrillation (AF) patients treated with nonvitamin K antagonist oral anticoagulant (NOAC) who are also using P-glycoprotein (P-gp) and CYP3A4 inhibitors, reports a study, noting the need for close monitoring of these individuals.

P-gp/CYP3A4 inhibitor use ups bleeding, mortality risks in NOAC-treated AF patients

26 Jun 2022

Diabetes, fertility treatment, family history up autism risk in infants

26 Jun 2022

A recent Egypt study has identified several maternal and neonatal factors contributing to the risk of autism spectrum disorders (ASD) in infants, including the use of assisted fertility treatments, family medical history, and threatened abortion.

Diabetes, fertility treatment, family history up autism risk in infants

26 Jun 2022

Novel oral neoadjuvant therapy shows promising phase II results

25 Jun 2022

The novel neoadjuvant therapy S-1, an oral fluoropyrimidine agent containing tegafur, gimeracil, and oteracil potassium, yields promising survival outcomes in high-risk patients with resectable pancreatic ductal adenocarcinoma, a recent study has found.

Novel oral neoadjuvant therapy shows promising phase II results

25 Jun 2022

News & Updates

Filter by Specialty:

Specialty:

Regular statin use offers protection against diabetes in acute pancreatitis patients

Regular statin use offers protection against diabetes in acute pancreatitis patients

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Glargine, degludec improve glycaemic control in patients switching from first-gen insulin

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data

Antibody responses to COVID-19 vaccines in older people: Recent evidence & local data

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Calorie restriction blunts long-term kidney decline, improves CV risk factors in obese T2D patients

Revacept beneficial to patients with symptomatic ICA stenosis

Revacept beneficial to patients with symptomatic ICA stenosis

Specific carbohydrate diet may improve symptoms for some IBD patients

Specific carbohydrate diet may improve symptoms for some IBD patients

Add-on baclofen eases reflux in certain PPI-refractory GERD patients

Add-on baclofen eases reflux in certain PPI-refractory GERD patients

P-gp/CYP3A4 inhibitor use ups bleeding, mortality risks in NOAC-treated AF patients

P-gp/CYP3A4 inhibitor use ups bleeding, mortality risks in NOAC-treated AF patients

Diabetes, fertility treatment, family history up autism risk in infants

Diabetes, fertility treatment, family history up autism risk in infants

Novel oral neoadjuvant therapy shows promising phase II results

Novel oral neoadjuvant therapy shows promising phase II results